SyzOnc
SyzOnc is a cancer treatment platform focused on developing therapies for solid tumor patients with no effective treatment options. Utilizing AI tools, the Cell Painting assay, and unique cell-based models of the tumor microenvironment, SyzOnc aims to identify promising therapeutic leads. The company differentiates itself through its systems-level approach to cancer therapeutics, targeting matrix-rich solid tumors with poor survival rates. Founded by experts from the Broad Institute and UPenn, SyzOnc integrates world-class cancer and machine learning research to yield next-generation targets and therapies, addressing the complexities of solid tumor biology.
SyzOnc
SyzOnc is a cancer treatment platform focused on developing therapies for solid tumor patients with no effective treatment options. Utilizing AI tools, the Cell Painting assay, and unique cell-based models of the tumor microenvironment, SyzOnc aims to identify promising therapeutic leads. The company differentiates itself through its systems-level approach to cancer therapeutics, targeting matrix-rich solid tumors with poor survival rates. Founded by experts from the Broad Institute and UPenn, SyzOnc integrates world-class cancer and machine learning research to yield next-generation targets and therapies, addressing the complexities of solid tumor biology.